Cargando…

Ovarian Cancer Biomarker Discovery Based on Genomic Approaches

Ovarian cancer presents at an advanced stage in more than 75% of patients. Early detection has great promise to improve clinical outcomes. Although the advancing proteomic technologies led to the discovery of numerous ovarian cancer biomarkers, no screening method has been recommended for early dete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jung-Yun, Kim, Hee Seung, Suh, Dong Hoon, Kim, Mi-Kyung, Chung, Hyun Hoon, Song, Yong-Sang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Cancer Prevention 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189448/ https://www.ncbi.nlm.nih.gov/pubmed/25337559 http://dx.doi.org/10.15430/JCP.2013.18.4.298

Ejemplares similares

Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020)

Protective Effect of Progesterone during Pregnancy against Ovarian Cancer
por: Han, Kyung Hee, et al.
Publicado: (2013)

Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2023)

Unfolded protein response to autophagy as a promising druggable target for anticancer therapy
por: Suh, Dong Hoon, et al.
Publicado: (2012)

Cyclooxygenase-1 and -2: Molecular Targets for Cervical Neoplasia
por: Kim, Hee Seung, et al.
Publicado: (2013)

Impact of Underweight after Treatment on Prognosis of Advanced-Stage Ovarian Cancer
por: Kim, Se Ik, et al.
Publicado: (2014)

Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial
por: Kim, Hee Seung, et al.
Publicado: (2017)

Metformin against Cancer Stem Cells through the Modulation of Energy Metabolism: Special Considerations on Ovarian Cancer
por: Kim, Tae Hun, et al.
Publicado: (2014)

Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study
por: Kim, Hee Seung, et al.
Publicado: (2016)

Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer
por: Luo, Yanlin, et al.
Publicado: (2016)

PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells
por: Kim, Boyun, et al.
Publicado: (2017)

SERPINB3 in the Chicken Model of Ovarian Cancer: A Prognostic Factor for Platinum Resistance and Survival in Patients with Epithelial Ovarian Cancer
por: Lim, Whasun, et al.
Publicado: (2012)

Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles
por: Kim, Se Ik, et al.
Publicado: (2020)

Correction: SERPINB3 in the Chicken Model of Ovarian Cancer: A Prognostic Factor for Platinum Resistance and Survival in Patients with Epithelial Ovarian Cancer
por: Lim, Whasun, et al.
Publicado: (2013)

ROS Accumulation by PEITC Selectively Kills Ovarian Cancer Cells via UPR-Mediated Apoptosis
por: Hong, Yoon-Hee, et al.
Publicado: (2015)

Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
por: Lee, Hee Jun, et al.
Publicado: (2013)

Development of Web-Based Nomograms to Predict Treatment Response and Prognosis of Epithelial Ovarian Cancer
por: Kim, Se Ik, et al.
Publicado: (2019)

L1 Cell Adhesion Molecule Expression Is Associated With Pelvic Lymph Node Metastasis and Advanced Stage in Diabetic Patients With Endometrial Cancer: A Matched Case Control Study
por: Suh, Dong Hoon, et al.
Publicado: (2014)

Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
por: Kim, Se Ik, et al.
Publicado: (2019)

Are Three Additional Cycles of Chemotherapy Useful in Patients with Advanced-stage Epithelial Ovarian Cancer After a Complete Response to Six Cycles of Intravenous Adjuvant Paclitaxel and Carboplatin?†
por: Kim, Hee Seung, et al.
Publicado: (2008)

Machine Learning Models to Predict Survival Outcomes According to the Surgical Approach of Primary Radical Hysterectomy in Patients with Early Cervical Cancer
por: Kim, Se Ik, et al.
Publicado: (2021)

Pharmacological Unmasking Microarray Approach-Based Discovery of Novel DNA Methylation Markers for Hepatocellular Carcinoma
por: Jung, Namhee, et al.
Publicado: (2012)

Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas
por: Kim, Sewha, et al.
Publicado: (2019)

Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB
por: Han, Kyung Hee, et al.
Publicado: (2017)

Impact of CT-Determined Sarcopenia and Body Composition on Survival Outcome in Patients with Advanced-Stage High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020)

Genistein as a Potential Anticancer Agent against Ovarian Cancer
por: Lee, Jung-Yun, et al.
Publicado: (2012)

Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
por: Kim, Se Ik, et al.
Publicado: (2020)

Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma
por: Kwon, Byung Su, et al.
Publicado: (2018)

Impact of hemodynamic instability during cytoreductive surgery on survival in high-grade serous ovarian carcinoma
por: Kim, Se Ik, et al.
Publicado: (2022)

Identification of Metabolic Biomarkers Using Serial (18)F–FDG PET/CT for Prediction of Recurrence in Advanced Epithelial Ovarian Cancer
por: Kim, Tae Hun, et al.
Publicado: (2017)

Effect of BRCA1/2 Mutational Status on Survival Outcomes According to Secondary Cytoreductive Surgery and Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer: A Real-World Evidence Study
por: Kim, Se Ik, et al.
Publicado: (2023)

Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy
por: Seol, Aeran, et al.
Publicado: (2022)

Mitochondrial permeability transition pore as a selective target for anti-cancer therapy
por: Suh, Dong H., et al.
Publicado: (2013)

Biomarker Discovery of Acute Coronary Syndrome Using Proteomic Approach
por: Shin, Miji, et al.
Publicado: (2021)

From genome sequencing to the discovery of potential biomarkers in liver disease
por: Oh, Sumin, et al.
Publicado: (2020)

Genetic analysis of ovarian microcystic stromal tumor
por: Lee, Jae Hoon, et al.
Publicado: (2016)

A 6-year-old girl with vaginal spotting who was diagnosed with perivascular epithelioid cell neoplasm after vaginoscopic resection
por: Cho, Hyun-Jung, et al.
Publicado: (2014)

Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced‐stage ovarian cancer
por: Lee, Yong Jae, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0u3shjfup9bsipnaqc2bl19nss